ArticleFrontiers in cellular and infection microbiology2022

RH5.1-CyRPA-Ripr antigen combination vaccine shows little improvement over RH5.1 in a preclinical setting.

Julie Healer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.